News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
610,933 Results
Type
Article (56143)
Company Profile (207)
Press Release (554583)
Multimedia
Podcasts (83)
Webinars (13)
Section
Business (164780)
Career Advice (2458)
Deals (30306)
Drug Delivery (121)
Drug Development (78349)
Employer Resources (153)
FDA (16317)
Job Trends (13561)
News (297684)
Policy (31951)
Tag
Academia (2597)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (89)
Alliances (42400)
ALS (90)
Alzheimer's disease (1453)
Antibody-drug conjugate (ADC) (151)
Approvals (16279)
Artificial intelligence (264)
Autoimmune disease (27)
Automation (12)
Bankruptcy (323)
Best Places to Work (10605)
BIOSECURE Act (22)
Biosimilars (115)
Biotechnology (150)
Bladder cancer (85)
Brain cancer (31)
Breast cancer (303)
Cancer (2430)
Cardiovascular disease (193)
Career advice (2060)
Career pathing (33)
CAR-T (168)
Cell therapy (456)
Cervical cancer (21)
Clinical research (63359)
Collaboration (808)
Company closure (1)
Compensation (553)
Complete response letters (29)
COVID-19 (2682)
CRISPR (45)
C-suite (236)
Cystic fibrosis (98)
Data (2170)
Decentralized trials (2)
Denatured (15)
Depression (52)
Diabetes (276)
Diagnostics (6080)
Digital health (16)
Diversity (5)
Diversity, equity & inclusion (42)
Drug discovery (118)
Drug pricing (123)
Drug shortages (30)
Duchenne muscular dystrophy (100)
Earnings (64723)
Editorial (45)
Employer branding (20)
Employer resources (138)
Events (91831)
Executive appointments (689)
FDA (17590)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (714)
Gene editing (109)
Generative AI (22)
Gene therapy (331)
GLP-1 (802)
Government (4344)
Grass and pollen (6)
Guidances (66)
Healthcare (17199)
Huntington's disease (24)
IgA nephropathy (31)
Immunology and inflammation (142)
Indications (29)
Infectious disease (2834)
Inflammatory bowel disease (139)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (94)
Interviews (457)
IPO (14979)
IRA (48)
Job creations (3374)
Job search strategy (1711)
Kidney cancer (11)
Labor market (32)
Layoffs (530)
Leadership (23)
Legal (7508)
Liver cancer (81)
Lung cancer (345)
Lymphoma (158)
Machine learning (7)
Management (53)
Manufacturing (311)
MASH (74)
Medical device (11898)
Medtech (11901)
Mergers & acquisitions (15857)
Metabolic disorders (745)
Multiple sclerosis (76)
NASH (22)
Neurodegenerative disease (99)
Neuropsychiatric disorders (33)
Neuroscience (1999)
NextGen: Class of 2025 (5663)
Non-profit (4078)
Now hiring (24)
Obesity (408)
Opinion (233)
Ovarian cancer (78)
Pain (87)
Pancreatic cancer (87)
Parkinson's disease (150)
Partnered (18)
Patents (239)
Patient recruitment (112)
Peanut (49)
People (48838)
Pharmaceutical (46)
Pharmacy benefit managers (21)
Phase I (19680)
Phase II (27553)
Phase III (21428)
Pipeline (1210)
Policy (168)
Postmarket research (2620)
Preclinical (8358)
Press Release (37)
Prostate cancer (113)
Psychedelics (35)
Radiopharmaceuticals (264)
Rare diseases (409)
Real estate (4882)
Recruiting (60)
Regulatory (22340)
Reports (33)
Research institute (2356)
Resumes & cover letters (406)
Rett syndrome (5)
RNA editing (5)
RSV (49)
Schizophrenia (78)
Series A (126)
Series B (82)
Service/supplier (10)
Sickle cell disease (57)
Special edition (16)
Spinal muscular atrophy (152)
Sponsored (33)
Startups (3090)
State (1)
Stomach cancer (16)
Supply chain (73)
Tariffs (46)
The Weekly (67)
Vaccines (794)
Venture capitalists (44)
Weight loss (294)
Women's health (32)
Worklife (20)
Date
Today (38)
Last 7 days (848)
Last 30 days (2489)
Last 365 days (31732)
2025 (10742)
2024 (33774)
2023 (37949)
2022 (48572)
2021 (52304)
2020 (49619)
2019 (41270)
2018 (31196)
2017 (30732)
2016 (29412)
2015 (32878)
2014 (26168)
2013 (21822)
2012 (23245)
2011 (23518)
2010 (22038)
Location
Africa (774)
Alabama (47)
Alaska (6)
Arizona (186)
Arkansas (12)
Asia (36220)
Australia (6553)
California (5884)
Canada (1732)
China (498)
Colorado (250)
Connecticut (284)
Delaware (138)
Europe (86725)
Florida (880)
Georgia (189)
Hawaii (1)
Idaho (48)
Illinois (494)
India (26)
Indiana (282)
Iowa (11)
Japan (153)
Kansas (95)
Kentucky (22)
Louisiana (7)
Maine (65)
Maryland (893)
Massachusetts (4464)
Michigan (188)
Minnesota (358)
Mississippi (1)
Missouri (73)
Montana (18)
Nebraska (20)
Nevada (57)
New Hampshire (55)
New Jersey (1657)
New Mexico (20)
New York (1676)
North Carolina (971)
North Dakota (6)
Northern California (2598)
Ohio (183)
Oklahoma (9)
Oregon (30)
Pennsylvania (1278)
Puerto Rico (10)
Rhode Island (23)
South America (1122)
South Carolina (21)
South Dakota (1)
Southern California (2207)
Tennessee (93)
Texas (926)
United States (22159)
Utah (159)
Virginia (138)
Washington D.C. (62)
Washington State (536)
West Virginia (3)
Wisconsin (58)
610,933 Results for "texas children s cancer centre".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Texas Children’s Hospital and UT MD Anderson Announce Joint Venture to End Childhood Cancer
February 19, 2025
·
4 min read
Press Releases
Scott Stringer Named Chairman of the Board at the National Children’s Cancer Society
March 31, 2025
·
3 min read
Policy
RFK Considers Pulling COVID-19 From CDC’s Vaccine Guidelines for Children:
Politico
Such a change would put the U.S. more in line with guidance in other countries and with the World Health Organization, which recommends one dose for children and adolescents only if they have comorbidities.
April 23, 2025
·
3 min read
·
Tristan Manalac
Policy
CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer
CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system to fight cancer, announced that its UCLA research team has created a promising new drug candidate for treating recurrent Ewing sarcoma, a deadly children’s cancer.
April 16, 2024
·
4 min read
Bladder cancer
Pfizer’s Subcutaneous PD-1 Cuts Risks in Bladder Cancer but Misses Survival Endpoint
Pfizer’s sasanlimab, when used with standard of care, reduced the likelihood of disease recurrence or progression, death due to any cause or persistence of cancer cells by 32% in patients with high-risk non-muscle invasive bladder cancer.
April 28, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Cincinnati Children’s and GE HealthCare build collaborative research program to drive pediatric imaging innovation
April 10, 2025
·
6 min read
Press Releases
Children’s Hospital Los Angeles Team Is First in World to Investigate Cardiac Xenotransplant as a ‘Bridge’ for Babies
April 29, 2025
·
5 min read
Business
New Transformative Leadership Team Announced for Texas Children’s World-Renowned Heart Center
Texas Children’s Hospital is pleased to announce the new executive leadership structure at the Texas Children’s Heart Center, which has been ranked number one in the nation for pediatric cardiology and heart surgery by U.S. News and World Report for seven consecutive years.
May 3, 2024
·
6 min read
Breast cancer
Gilead’s Trodelvy, With Keytruda, Slows Disease Progression in Triple-Negative Breast Cancer
Combining Trodelvy with Keytruda and pushing it into the frontline setting could “potentially double” the ADC’s market in metastatic triple-negative breast cancer, according to analysts at Truist Securities.
April 22, 2025
·
2 min read
·
Tristan Manalac
Approvals
ARS Wins FDA Approval for Neffy Spray for Children in Anaphylaxis
Neffy 1 mg is the “first significant innovation” for epinephrine delivery in small children aged 4 years and up in over 35 years, according to ARS Pharmaceuticals.
March 6, 2025
·
2 min read
·
Tristan Manalac
1 of 61,094
Next
